Evidence map›Paper›PMID 39594820›Full record

ReviewCancers2024

Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis.

Nicholas Hannah, Catherine Yu, Leya Nedumannil, James Haridy, Grace Kong, Alex Boussioutas, Siddharth Sood

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Diagnostic Performance of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Trial
  2. Correlation ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Dual-tracer positron emission tomography-computed tomography withQuantitative imaging in medicine and surgery · 2026
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicholas HannahMelbourne Medical School, The University of Melbourne, Parkville, Melbourne, VIC 3052, Australia.ORCID 0000-0002-1146-4308
Catherine YuDepartment of Gastroenterology & Hepatology, The Northern Hospital, Northern Health, Epping, Melbourne, VIC 3076, Australia.
Leya NedumannilDepartment of Gastroenterology & Hepatology, The Northern Hospital, Northern Health, Epping, Melbourne, VIC 3076, Australia.ORCID 0009-0002-1170-2828
James HaridyDepartment of Gastroenterology & Hepatology, The Royal Melbourne Hospital, Melbourne Health, Parkville, Melbourne, VIC 3052, Australia.ORCID 0000-0002-1534-3466
Grace KongMolecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia.
Alex BoussioutasMelbourne Medical School, The University of Melbourne, Parkville, Melbourne, VIC 3052, Australia.
Siddharth SoodMelbourne Medical School, The University of Melbourne, Parkville, Melbourne, VIC 3052, Australia.ORCID 0000-0002-9341-4792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is widely used in prostate cancer. Recent studies indicate hepatocellular carcinoma (HCC) demonstrates PSMA PET uptake. The diagnostic accuracy of PSMA PET for HCC is not known. We conducted a systematic review and meta-analysis of studies assessing

Indexed as

diagnosisHCChepatocellular carcinomaPETPSMA

Identifiers

PMID39594820
PMCPMC11592426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.